PMAM
RVNC

Picton Mahoney Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Picton Mahoney Asset Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-134,388
Closed -$3.4M – 472
2023
Q2 		$3.4M Buy
134,388
+5,033
+4% +$127K 0.15% 167
2023
Q1 		$4.17M Buy
129,355
+29,375
+29% +$946K 0.19% 159
2022
Q4 		$1.84M Buy
99,980
+38,580
+63% +$712K 0.09% 306
2022
Q3 		$1.66M Buy
+61,400
New +$1.66M 0.06% 361